CGEM — Cullinan Therapeutics, Inc. stock price, charts and financials

QT86Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.28
+0.55+3.10%
OverviewShort InterestFilings
CGEMQT86Cullinan Therapeutics, Inc.·NASDAQ
18.28+3.10%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 10, 20268-KCurrent report
Jun 08, 20268-KCurrent report
May 18, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 06, 20264Statement of changes in beneficial ownership
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026S-3ASRS-3ASR
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026ARSAnnual report to shareholders
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 366
Page
▼
/ 15